Article 04 Jun 2026 Supreme Court Reverses Federal Circuit In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision For “Skinny Labels” And Generic Drug Competition United States IP
Article 15 Jan 2026 Supreme Court Hears Oral Argument In Hikma Pharmaceuticals USA, Inc. United States IP